Health Management Associates, based in Naples, Fla., has said two government subpoenas it received apply to the company’s entire system and may involve alleged anti-kickback and False Claims Act violations, according to a Wall Street Journal report.
The subpoenas were issued by the U.S. Department of Health and Humans Services’ Office of Inspector General in August. One requested information on physician referrals and management at HMA’s “whole-hospital physician joint ventures.” The second requested information on emergency department management and the use of Pro-Med software.
HMA said the subpoenas may have been served under the qui tam, or whistleblower, provisions of the False Claims Act.
HMA said it is cooperating with the ongoing investigations.
Related Articles on HMA:
HMA Receives Subpoenas From Office of Inspector General
HMA Closes Purchase of Tennessee’s Mercy Health Partners
Health Management Associates’ Revenue, Income up in 3Q
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
